Moore Michael 4
4 · VIEMED HEALTHCARE, INC. · Filed Feb 2, 2026
Research Summary
AI-generated summary of this filing
Viemed (VMD) President Michael Moore Receives Awards; Shares Withheld
What Happened
Michael Moore, President of Viemed Healthcare, reported vesting and related transactions on January 29, 2026. A mix of Restricted Stock Units (RSUs) and cash‑settled phantom share units vested (totaling multiple lots of 26,842 and 8,947 shares). To satisfy tax obligations, 7,342 shares were withheld by the issuer (reported as F: tax withholding) valued at $7.48 per share for $54,918. Separately, 8,947 phantom shares were settled for cash to the company at $7.48 per share, producing $66,924. Some derivative‑related items are reported with $0 per‑share amounts reflecting cash settlement mechanics rather than an open‑market sale.
Key Details
- Transaction date: January 29, 2026; Form 4 filed February 2, 2026.
- Reported amounts:
- 26,842 shares (RSU/derivative) — acquisition/vesting entries reported.
- 8,947 phantom shares — vested and cash‑settled for $7.48/share = $66,924 (disposition to issuer).
- 7,342 shares withheld to cover taxes at $7.48/share = $54,918 (tax withholding).
- Price basis: $7.48 per share is the market close price for January 29, 2026 (per filing).
- Transaction codes: M = exercise/conversion of derivative (vesting of RSUs/phantoms); F = shares withheld to satisfy tax liability.
- Shares owned after the transaction: not specified in the supplied data.
- Footnotes: RSUs = contingent rights to one share each; phantom shares are cash‑settled equivalents (see F1–F6 in filing).
Context
- These transactions are compensation‑related (vesting of RSUs and phantom share units) and include routine tax withholding and cash settlement — common for executives receiving equity awards.
- The cash settlement and share withholding are effectively a cashless outcome: the economic value of phantom units was paid to the insider and some vested shares were retained by the company to cover taxes.
- Such events are standard and do not necessarily signal the insider’s market view or a discretionary open‑market sale.
Insider Transaction Report
- Exercise/Conversion
Common Shares
[F1]2026-01-29+26,842→ 196,432 total - Tax Payment
Common Shares
[F2][F3]2026-01-29$7.48/sh−7,342$54,918→ 189,090 total - Exercise/Conversion
Common Shares
[F4]2026-01-29+8,947→ 198,037 total - Disposition to Issuer
Common Shares
[F3]2026-01-29$7.48/sh−8,947$66,924→ 189,090 total - Exercise/Conversion
Restricted Stock Units
[F1][F5]2026-01-29−26,842→ 26,842 totalExp: 2027-01-29→ Common Shares (26,842 underlying) - Exercise/Conversion
Phantom Share Units
[F4][F6]2026-01-29−8,947→ 8,947 totalExp: 2027-01-29→ Common Shares (8,947 underlying)
- 1,722,614(indirect: By LLC)
Common Shares
Footnotes (6)
- [F1]Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
- [F2]Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
- [F3]Per share value is based on the market closing price of the common shares for January 29, 2026.
- [F4]Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
- [F5]Restricted Stock Units (RSUs) granted to reporting person on January 29, 2024, which vest in three equal annual installments beginning on the first anniversary of the grant date.
- [F6]Represents an award granted on January 29, 2024 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.